June S&P 500 E-Mini futures (ESM24) are down -0.07%, and June Nasdaq 100 E-Mini futures (NQM24) are up +0.03% this morning as market participants refrained from making big bets ahead of the eagerly awaited...
The company increased guidance, acquired a company, and had a stock sale.
The pharmaceutical company announced first-quarter earnings Thursday afternoon.
Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the launch of FDA-approved IHEEZO ™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) annual...
Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Applications (NDAs) for ILEVRO® (nepafenac ophthalmic suspension)...
Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2023, on Thursday, May 11, 2023, after...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Harrow Health, Inc. ("Harrow Health" or...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Harrow Health, Inc. ("Harrow Health" or...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Harrow Health, Inc. ("Harrow Health" or...
/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Harrow Health, Inc. ("Harrow Health" or...